Integrative Diabetes and Cardiovascular Diseases aims to provide a home for all types of scientific communications related to the diabetes/cardiovascular interrelationship which include genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research. The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. The American Heart Association stated in 1999 that "diabetes is a cardiovascular disease". The worldwide frequency of the diabetes mellitus especially type 2, which makes up about 90% of the diabetic population, has continuously and rapidly increased over the last decades. Moreover, 25% of patients with newly diagnosed type 2 diabetes already have coronary artery disease. Diabetes mellitus has become a diagnosis of considerable and ominous importance in cardiovascular medicine. Despite considerable improvements in the treatment of cardiovascular diseases, there is alarming evidence that patients with diabetes have hardly experienced any advantages from recent therapeutic achievements compared with their non-diabetic counterparts. Integrative Diabetes and Cardiovascular Diseases is an essential publication specifically dedicated to these issues.
Why publish your article in Integrative Diabetes and Cardiovascular Diseases?
Gratis open access policy allows maximum visibility of articles published in the journal as they are available to whole global audience. Integrative Diabetes and Cardiovascular Diseases offers a fast publication schedule where every work undergoes rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both full text and as a formatted PDF.
2018: Articles in Press